Skip to content
Policymakers and public health leaders have been playing a dangerous game when it comes to how they are preparing, or rather are not preparing, […]
Shionogi shows how a biotech firm can tackle AMR Read More »
“Cancer’s resistance to treatments is the biggest challenge faced today in oncology, and this resistance is the cause of death from the disease,” said
OncoXome is charging ahead with gene therapy to treat resistant cancers Read More »
In the “first in a series of projects Shell is considering at its chemicals facilities along the Gulf Coast to accelerate the transition from
Shell plans to turn oil refinery into biorefinery producing SAFs Read More »
A subvariant of Omicron by the name of BA.2.75.2 is the most recent strain of COVID-19 causing concern. This variant has already developed the
New Omicron subvariant could create challenges this fall Read More »
U.S. investment in sensitive, cutting-edge research abroad would be more tightly controlled under the proposed National Critical Capabilities Defense Act. The bipartisan legislation would
Bill would limit U.S. investment in foreign research Read More »
The Food and Drug Administration (FDA) on Thursday authorized a new medication intended to halt the progression of amyotrophic lateral sclerosis (ALS), also known
FDA approves new ALS drug funded partially by ‘Ice Bucket Challenge’ Read More »
Climate change poses an increasing number of challenges to food production and supply chains around the globe, and the world needs solutions. Luckily, the
USDA: Biotech can boost agriculture productivity, sustainability Read More »
In a monumental victory for the people in Oregon, biotech innovation, and the Biotechnology Innovation Organization (BIO), the Accelerated Approval pathway will be preserved
Oregon preserves Medicaid coverage for ‘Accelerated Approval’ drugs Read More »
The Biden-Harris Administration has released a National Strategy on Hunger, Nutrition, and Health ahead of today’s Conference on Hunger, Nutrition, and Health. In the
Biden releases new food strategy ahead of White House food summit Read More »
An experimental Alzheimer’s drug developed by Biotechnology Innovation Organization’s (BIO) members Eisai Co Ltd and Biogen slowed the cognitive and functional decline in a
Eisai and Biogen’s Alzheimer’s drug slows cognitive decline, study shows Read More »
